Why the study?
Liraglutide has anti-inflammatory and antioxidative effects that may benefit heart failure, prompting investigation into its effects on isoprenaline-induced myocardial injury and heart failure prevention.
Does liraglutide improve cardiac function and mitigate myocardial injury in a rat model of isoprenaline-induced heart failure?
Does liraglutide improve cardiac function and mitigate myocardial injury in a rat model of isoprenaline-induced heart failure?
Liraglutide restores cardiac function and mitigates myocardial injury in a rat model of isoprenaline-induced heart failure.
Answers are grounded in this paper and cite their sources.
May attenuate isoprenaline-induced myocardial injury in rats; leaves open translation to human HF.
BACKGROUND: Myocardial injury (MI) is characterized by an increased level of at least one cardiac troponin. Experimental MI can be induced by isoprenaline, a β-adrenergic agonist, and it can lead to heart failure (HF). Liraglutide is glucagon-like 1 peptide receptor agonist used in diabetes management, but it has anti-inflammatory and antioxidative effects, which can be beneficial in treatment of HF. The aim of this study was to investigate the effects of liraglutide on isoprenaline-induced MI and prevention of HF. METHODS: Male Wistar albino rats were divided into four groups: Con-received saline the first 2 days + saline the next 7 days; Iso-isoprenaline the first 2 days + saline the next 7 days; Lir-saline the first 2 days + liraglutide the next 7 days; Iso + Lir-isoprenaline the first 2 days + liraglutide the next 7 days. On day 10, blood samples were taken for biochemical analysis and oxidative stress marker evaluation, and hearts were isolated for pathohistological analysis. Cardiac function was assessed by electrocardiography (ECG) and echocardiography (ECHO). RESULTS: Liraglutide treatment significantly attenuated oxidative stress, repaired ECG and ECHO parameters, and mitigated myocardial morphological changes induced by isoprenaline. CONCLUSIONS: Liraglutide restores cardiac function in isoprenaline-induced HF.
No takes yet. Share an insight, caveat, or question.
Bajić et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: